William H. Rastetter stock trades
Director at Neurocrine Biosciences and Fate Therapeutics
1 open-market trade reported in the last 12 months: 1 sale for $2.7M. One sale was under a trading plan set up in advance. The newest was filed Nov 6, 2025.
The 2 companies William H. Rastetter files at
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 1 | ||
| 0 |
William H. Rastetter's trades, as filed
Open-market buys and sales, newest first, each with its Form 4 on the SEC's site. A Plan tag marks a sale under a trading plan set up in advance.
| Stock | Trade | Traded |
|---|---|---|
| SellPlan$2.7M | Nov 5, 2025SEC filing |
3 other filings on record (option exercises and stock unit conversion). Pro members see every trade, the shares William H. Rastetter held after each, and every filing.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Others who file at their companies
- Kyle Gano
- Matt Abernethy
- Ingrid Delaet
- Darin Lippoldt
- David W. Boyer
- Eric Benevich
- Jude Onyia
- Julie Cooke
- Sanjay Chandru Keswani
- Leslie V. Norwalk
- Gary A. Lyons
- Kevin Charles Gorman
- George J. Morrow
- Richard F. Pops
- Stephen A. Sherwin
- Christine A. Poon
- Johanna Mercier
- Shalini Sharp
- Bahram Valamehr
- Kamal Adawi
- Cindy Tahl
- Robert S. Epstein